Lung Cancer

Lung cancer is the world's most common cancer and kills more people than any other cancer. In 2008, approximately 1.52 million new cases of lung cancer were diagnosed worldwide, with 1.31 million people dying from the disease.(14) In the United States, an estimated 161,840 deaths, accounting for 29 percent of all cancer deaths, occurred in 2008, according to the American Cancer Society (ACS).
Lung Cancer

Lung cancer is a common and very serious form of cancer, with more than 40,000 people diagnosed with the condition each year in the UK. The symptoms of lung cancer do not present in the early stages, but when symptoms do eventually present, they usually include the following:

Read More

Overview

Feature Articles

Latest Lung Cancer News and Research

Leveraging the power of T cells for more effective and durable cancer immunotherapies

Leveraging the power of T cells for more effective and durable cancer immunotherapies

How COVID mRNA vaccines may make cancer treatments more effective

How COVID mRNA vaccines may make cancer treatments more effective

Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital™ PCR high complexity assays

Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital™ PCR high complexity assays

Oral targeted therapy shrinks tumors in over 70% of patients with HER2-mutant NSCLC

Oral targeted therapy shrinks tumors in over 70% of patients with HER2-mutant NSCLC

Study shows mRNA-based COVID vaccines enhance effectiveness of immune checkpoint therapy

Study shows mRNA-based COVID vaccines enhance effectiveness of immune checkpoint therapy

‘Cancer doesn’t care’: Citizen lobbyists unite to push past Washington’s ugly politics

‘Cancer doesn’t care’: Citizen lobbyists unite to push past Washington’s ugly politics

Digital health program increases lung cancer screening rates in high-risk individuals

Digital health program increases lung cancer screening rates in high-risk individuals

CRATERs identified as key sites for T cell-mediated tumor destruction

CRATERs identified as key sites for T cell-mediated tumor destruction

Scientists discover why a powerful leukemia drug fails in most patients

Scientists discover why a powerful leukemia drug fails in most patients

Osimertinib plus chemotherapy improves survival in EGFR-mutated lung cancer

Osimertinib plus chemotherapy improves survival in EGFR-mutated lung cancer

Blocking key protein restores healthy lung function and reduces fibrosis in mice

Blocking key protein restores healthy lung function and reduces fibrosis in mice

Thymic health found to predict immunotherapy success in cancer patients

Thymic health found to predict immunotherapy success in cancer patients

Mobile van brings advanced lung cancer screening to New Yorkers

Mobile van brings advanced lung cancer screening to New Yorkers

Study provides a roadmap for how health systems can improve lung cancer screening rates

Study provides a roadmap for how health systems can improve lung cancer screening rates

Quitting smoking after cancer diagnosis sharply improves survival, study finds

Quitting smoking after cancer diagnosis sharply improves survival, study finds

University Of California researchers, patients wary of Trump cuts even as some dollars flow again

University Of California researchers, patients wary of Trump cuts even as some dollars flow again

Housing support programs tied to improved cancer detection among seniors

Housing support programs tied to improved cancer detection among seniors

NCCN enhances widely used breast cancer guidelines with advanced digital features

NCCN enhances widely used breast cancer guidelines with advanced digital features

IASLC proposes new tumor budding-based grading system for lung squamous cell carcinoma

IASLC proposes new tumor budding-based grading system for lung squamous cell carcinoma

Bio-Rad extends partnership with Gencurix through strategic agreement for Droplet Digital™ PCR IVD oncology kits in Europe

Bio-Rad extends partnership with Gencurix through strategic agreement for Droplet Digital™ PCR IVD oncology kits in Europe

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.